Press releases | WebDisclosure

Basculer en Français

11294	Companies
250971	Keywords
179884	Articles
136841	Press releases

Home
Press releases

PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

PolyPeptide Group: Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG
Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG, valued at approximately CHF 1.46 billion. The Board of Directors of PolyPeptide recommends accepting the Offer

Board Of Directors Public Tender Offer PolyPeptide Group Offer Prospectus Samsung Peptide AG
REGULATED PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position, extends cash runway to Q1 2027. Cash inflows of €3.7M, debt reduction of over 30%. Phase 2 study in obesity in Q1 2027

Biophytis Financial Position Debt Reduction Obesity Study Cash Runway
REGULATED PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027. Position de trésorerie renforcée à 3,0 millions d'euros. Démarrage de l'étude de phase II dans l'obésité et joint-venture à Hong Kong sur le point de démarrer ses activités

Biophytis Hong Kong Trésorerie Obésité Phase II
PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Informations privilégiées / Autres communiqués
Advicenne retire la demande d'enregistrement de ADV7103 aux Etats-Unis pour le traitement de l'Acidose Tubulaire Rénale distale primaire, en raison de travaux complémentaires requis dans le domaine CMC

Advicenne Retrait ADV7103 Acidose Tubulaire Rénale Demande D'enregistrement
PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Inside Information / Other news releases
Advicenne voluntarily withdraws NDA for ADV7103 in the USA due to CMC-related work issues. Company hosting French webinar for shareholders. ADV7103 approved in EU, UK, KSA, UAE

Pharmaceutical Webinar Advicenne ADV7103 NDA Withdrawal
PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

LE GROUPE DEKUPLE POURSUIT LE DÉPLOIEMENT DE SA ROADMAP STRATÉGIQUE AMBITION 2030 ET ENREGISTRE UNE CROISSANCE SOLIDE AU PREMIER SEMESTRE 2026
Le Groupe DEKUPLE enregistre une croissance solide au premier semestre 2026, portée par le Marketing Digital et l'International, confirmant la solidité de son modèle intégré de Communication et Data Marketing

Croissance Marketing Digital Data Marketing Communication DÉKUPLE
PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

DEKUPLE GROUP CONTINUES TO ROLL OUT ITS AMBITION 2030 STRATEGIC ROADMAP AND DELIVERS SOLID GROWTH IN THE FIRST HALF OF 2026
DEKUPLE Group reports solid growth in revenue and net revenue in the first half of 2026 due to Digital Marketing and International expansion

Revenue Growth Digital Marketing Financial Performance International Expansion DÉKUPLE Group
PRESS RELEASE

published on 08/31/2026 at 06:59, 2 months 8 days ago

Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
Biophytis renforce sa situation financière en étendant son horizon de trésorerie au T1 2027 grâce à l'exercice des bons de souscription d'actions 2026 et à la réduction de sa dette. Démarrage imminent d'une étude de phase II dans l'obésité

Biophytis Restructuration Financière Trésorerie Étude Clinique Obésité
PRESS RELEASE

published on 08/31/2026 at 06:59, 2 months 8 days ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position and extends cash runway to Q1 2027 through new resources and debt reduction, starting Phase 2 obesity study in Q1 2027

Biophytis Financial Position Debt Reduction Phase 2 Study Cash Runway
PRESS RELEASE

published on 08/31/2026 at 06:30, 2 months 8 days ago

HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management
Huawei unveils the HUAWEI WATCH D3 at ESC Congress 2026, setting a new standard for wrist-based blood pressure management. Learn about this innovative health technology

Wearable Technology Huawei Blood Pressure ESC Congress 2026 HUAWEI WATCH D3

Accesswire

Published on 11/06/2026 at 22:15, 2 days 7 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 17 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 17 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 17 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 20 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 01:55, 4 hours 9 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 17 hours 54 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 19 hours 49 minutes ago

2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 16 hours ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 9 hours ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing

Les Echos

Published on 11/06/2026 at 19:06, 2 days 10 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 11 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 11 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 11 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 2 days 12 hours ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE